Patent ID: 11883377
Assignee: VAXA TECHNOLOGIES LTD
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A food product or a nutritional supplement comprising an EPA (eicosapentaenoic acid) composition, the EPA composition comprising between 15 wt % and 90 wt % of EPA and between 10 wt % and 50 wt % of polar lipids, wherein:
the polar lipids comprise phospholipid-conjugates and glycolipid-conjugates;
between 3 wt % and 25 wt % of the EPA in the composition is a phospholipid-conjugate;
between 3 wt % and 25 wt % of the EPA in the composition is a glycolipid-conjugate;
between 15 wt % and 35 wt % of the EPA in the composition is a triglyceride-conjugate or a diglyceride-conjugate; and
the EPA composition does not comprise docosahexaenoic acid (DHA) and is suitable for human consumption.